Our objective is to determine the biochemical and physiological mechanisms underlying the efficacy and biocompatibility, of fluorochemical emulsions. The proposed work continues our investigation of long-term hypothermic cardiac preservation using APE-LM, a novel fluorochemical emulsion composed of perfluoroperhydrophenanthrene in egg yolk phospholipid. We have found that APE-LM exerts a specific cardioprotective effect in preserving mammalian (rat and rabbit) hearts for periods of at least 12-24 hr with 100% recovery of physiological function.
The specific aims of the proposed work are to (a) determine the mechanism by which APE-LM exerts this unexpected salutary effect, and (b) to quantify the recovery of APE-LM-preserved rat and rabbit hearts after they are transplanted and reperfused in vivo. We postulate that APE-LM's effect is mediated by its novel formulation primarily by providing a higher 02 content, a lipid emulsifier, and superior physical properties (small emulsion particle size, low viscosity). We will determine how preservation is affected when components of the preservation medium are varied, when 02 content of the medium is varied, and when 02 delivery to the heart is varied. We will determine how cardiac membrane integrity and post-preservation function are affected by the composition, particularly the cholesterol content, of the egg yolk phospholipid emulsifier. Isolated working rat and rabbit heart preparations will be used to quantify contractile, output, work, flow, energetic, metabolic, and structural characteristics of fresh, preserved, and post-transplant hearts. In addition, various biochemical-and physiological indices of myocardial membrane integrity, oxygenation, mitochondrial function, and energy supply/utilization will be measured to suggest possible mechanisms of reversible vs. irreversible myocardial damage and to obtain a practical index of myocardial viability in the preservation setting. The proposed experiments are directed toward preservation and transplantation of large mammalian hearts using fluorochemical emulsions. Our research is also designed to yield fundamental information on (a) the interaction of fluorochemical emulsions with biological systems, which has application in the broad areas of red cell substitutes and lipid-encapsulated substances in general, and (b) the mechanisms and strategies to improve cardiac recovery after preservation and reperfusion.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL030065-07
Application #
3341124
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1988-04-01
Project End
1994-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
Schools of Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Segel, Leigh D; vonHaag, Derek W; Zhang, Jie et al. (2002) Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J Heart Lung Transplant 21:804-11
Segel, L D; Follette, D M; Baker, J M et al. (1998) Recovery of sheep hearts after perfusion preservation or static storage with crystalloid media. J Heart Lung Transplant 17:211-21
Segel, L D; Follette, D M (1998) Cardiac function and glycogen content after twenty-four-hour preservation with various metabolic substrates. J Heart Lung Transplant 17:299-305
Segel, L D; Follette, D M; Castellanos, L M et al. (1997) Steroid pretreatment improves graft recovery in a sheep orthotopic heart transplantation model. J Heart Lung Transplant 16:371-80
Smolens, I A; Follette, D M; Berkoff, H A et al. (1995) Incomplete recovery of working heart function after twenty-four-hour preservation with a modified University of Wisconsin solution. J Heart Lung Transplant 14:906-15
Segel, L D; Follette, D M; Iguidbashian, J P et al. (1994) Posttransplantation function of hearts preserved with fluorochemical emulsion. J Heart Lung Transplant 13:669-80
Segel, L D; Follette, D M (1993) Long-term heart preservation by intermittent perfusion with crystalloid medium. J Thorac Cardiovasc Surg 106:811-22
Segel, L D; Follette, D M; Contino, J P et al. (1993) Importance of substrate enhancement for long-term heart preservation. J Heart Lung Transplant 12:613-23
Segel, L D; Minten, J M; Schweighardt, F K (1992) Fluorochemical emulsion APE-LM substantially improves cardiac preservation. Am J Physiol 263:H730-9
Minten, J; Segel, L D; Van Belle, H et al. (1991) Differences in high-energy phosphate catabolism between the rat and the dog in a heart preservation model. J Heart Lung Transplant 10:71-8

Showing the most recent 10 out of 20 publications